|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 209.15 USD | -0.32% |
|
+0.98% | +18.84% |
| 08-13 | Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.32% | +0.98% | +1.53% | +8.40% | +18.84% | +50.90% | -20.02% | -40.21% | -33.35% | 31B | |
| +0.30% | -0.26% | +19.10% | +15.42% | +4.41% | +38.86% | +1.15% | +24.48% | +95.77% | 80.23B | |
| -1.02% | -1.34% | +10.89% | +9.09% | -8.67% | -2.54% | +30.42% | -0.51% | - | 50.64B | |
| +1.46% | -4.31% | -9.99% | -9.11% | -9.72% | +11.90% | +164.55% | +118.59% | +197.43% | 46.87B | |
| +17.44% | +14.37% | +29.04% | +64.43% | -8.36% | -41.69% | -41.53% | -46.11% | +46.90% | 46.34B | |
| +1.80% | +7.77% | +4.27% | +31.44% | +118.58% | +130.05% | -39.33% | -83.96% | - | 25.28B | |
| +2.78% | +1.60% | +5.33% | +29.58% | +25.04% | +42.08% | +92.34% | +63.23% | +61.48% | 24.36B | |
| -0.58% | -0.78% | +2.49% | +18.06% | +24.33% | -6.97% | +201.43% | +38.60% | - | 20.81B | |
| +3.95% | +1.64% | -0.87% | +3.81% | +37.56% | +67.20% | +120.52% | +153.07% | +361.03% | 16.08B | |
| +0.04% | -5.65% | -1.83% | +20.81% | +4.45% | +55.67% | +181.20% | +61.26% | - | 15.61B | |
| -1.10% | -9.77% | +47.63% | +10.62% | -9.19% | -6.59% | +805.10% | +531.24% | +6,482.40% | 15.47B | |
| -1.07% | -3.25% | +11.83% | +28.62% | +12.13% | +15.82% | -25.46% | -12.73% | -28.57% | 13.04B | |
| +1.22% | -2.09% | -5.97% | -5.03% | +18.41% | +98.02% | +212.30% | +928.88% | +2,866.67% | 11.19B | |
| +1.04% | +1.25% | -5.39% | +9.61% | +36.18% | +123.42% | +185.00% | +494.95% | - | 9.83B | |
| +4.93% | -0.38% | +32.56% | +153.02% | +292.21% | +342.43% | +568.15% | +27.81% | - | 7.44B | |
| -0.47% | -1.86% | +8.11% | +7.94% | -8.28% | -21.46% | -27.46% | -51.80% | -49.02% | 6.86B | |
| -1.01% | +9.63% | +15.48% | +31.27% | +9.03% | +18.75% | +74.96% | -1.76% | - | 6.62B | |
| +0.81% | +4.86% | +10.71% | +6.26% | +18.76% | +36.23% | +276.31% | +269.81% | - | 6.43B | |
| +3.17% | +3.46% | +23.82% | +40.12% | +91.95% | +137.21% | +383.39% | +541.65% | - | 5.99B | |
| -1.63% | -2.79% | +3.71% | -25.15% | -34.11% | -45.83% | -51.94% | -75.98% | - | 5.64B | |
| Average | +1.59% | -0.27% | +10.12% | +22.46% | +31.68% | +52.17% | +154.56% | +147.03% | +1,000.07% | 22.29B | |
| Weighted average by Cap. | +2.34% | -0.22% | +10.45% | +19.98% | +17.22% | +33.75% | +93.42% | +79.55% | +538.78% |
- Stock Market
- Stocks
- BIIB Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
